Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-02-23 @ 2:22 AM
Study NCT ID:
NCT05423769
Status:
COMPLETED
Last Update Posted:
2024-08-23
First Post:
2022-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
Sponsor:
Hikma Pharmaceuticals LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HIK-SPH-2021-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None